European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

MT Newswires Live06-15 23:09

European equities traded in the US as American depositary receipts started the week significantly higher late Monday morning, climbing 1.83% to 2,900.33 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and semiconductor company Sequans Communications (SQNS), which rose 11% and 6.7% respectively. They were followed by internet browser company Opera (OPRA) and lender Banco Santander (SAN), which were up 3.3% and 2.7% respectively.

The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which dropped 5.6% and 4.3% respectively. They were followed by medical device maker EDAP TMS (FOCL) and pharmaceutical company Sanofi (SNY), which were down 1.4% and 0.6%.

The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which advanced 3.7% and 3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Biodexa Pharmaceuticals (BDRX), which increased 2.7% and 2.3% respectively.

The decliners from the UK and Ireland were led by oil and gas companies Shell (SHEL) and BP (BP), which fell 4% and 3.3% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and biotech firm Trinity Biotech (TRIB), which lost 2.9% and 1.3% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment